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Screening for oral cancersdWhich method is most effective?Oral cancer, an often fatal disease, has the fourth highest
incidence of malignancy in males in Taiwan. Oral squamous
cell carcinoma (OSCC) accounts for >95% of all oral malig-
nancies. Oral cancer is associated with chronic irritating factors,
such as tobacco, smoking, alcohol and betel quid (BQ) use.
Cigarette smoking and alcohol drinking are the major risk
factors in Western countries, whereas BQ use and smoking are
the major factors in the cause of oral cancer in South Asia,
Southeast Asia and Taiwan.1e3 Unfortunately, w50% of new
cases at their first visit to our medical center often present with
advanced stages.4,5 The overall 5-year survival rate of these
patients is poor despite recent advances in surgery, radiotherapy
and chemotherapy.5 It is generally accepted that prevention and
screening of oral cancer are equally important, and the diag-
nosis of oral cancer at an early stage allows for less aggressive
treatment, improves quality of life and the overall 5-year
survival rate.6 Visual examination of the oral cavity has tradi-
tionally been the preferred approach for the detection of oral
mucosal abnormalities,7 including Chang et al’s publication in
this issue of the Journal of the Chinese Medical Association.8
There are other early detection methods that have been
developed by many researchers. Use of toluidine blue (TB), an
acidophilic dye that stains DNA andRNA, is based on the theory
that the content of acidic cellular components in dysplastic
tissue is greater than that in nondysplastic tissue. The clinician
brushes the dye onto the oral mucosa then examines the oral
mucosa for increased cellular staining.9 Although useful as an
adjunct to clinical examination, the specificity of TB staining is
limited because cells undergoing inflammatory changes and
benign hyperplasia may also retain dye, leading to false-positive
results. The overall sensitivity of TB staining ranges from 0.78
to 1.00 and the specificity ranges from 0.31 to 1.00.10 Oral
cytology is another diagnostic technique used to sample oral
tissue for histomorphological analysis, which includes cyto-
morphometry, DNA cytometry and immunocytochemical anal-
ysis.9 The use of oral cytology in the detection of dysplastic
lesions shows considerable promise, but has been limited thus
far by variable false-positive and false-negative results.9,10
The current identification and diagnosis of precancerous
and cancerous lesions relies on the histological and cytological
examination performed by a pathologist after suspicious tissue
is biopsied. Although these methods represent the gold stan-
dard for cancer diagnosis, they have several limitations in oral
screening. Tissue biopsy is invasive, expensive and often1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.10.003time-consuming. The diagnostic interpretation of the tissue
sample has been shown to vary among pathologists, and the
pathologic criteria for the identification of precancerous lesions
are not well defined.11 In addition, early precancerous changes
are frequently undetectable by conventional visual inspection,
leading to missed opportunities for diagnosis. Optical tech-
nologies show the potential to provide real-time assessment
through a minimally invasive route, eliminating lengthy wait-
ing time and the need for tissue biopsy. Although the benefits of
optical technologies are currently limited in clinical practice,
the achievement of a highly sensitive and specific optically
determined histopathologic diagnosis, an optical biopsy, has
the potential to revolutionize medical practice. As the most
thoroughly investigated optical techniques for the detection
and characterization of oral lesions, autofluorescence spec-
troscopy and imaging systems are capable of distinguishing
normal oral mucosa from cancerous lesions. Research suggests
that autofluorescence spectroscopy is exceedingly accurate in
distinguishing lesions from healthy oral mucosa (sensitivity
82e100%, specificity 63e100%), although there is a lack of
compelling evidence for the discrimination between lesion
types.12 In addition to fluorescence spectroscopy and imaging
techniques, several optical diagnostic systems have demon-
strated potential for the successful evaluation of the oral cavity.
A recent study using a multispectral imaging system (fluores-
cence, narrow-band imaging and orthogonal polarized reflec-
tance) demonstrated that oral lesion borders change with each
imaging modality, suggesting that multimodal imaging can
provide important diagnostic information not available through
conventional white-light examination or through the use of
a single imaging mode alone.13 Trimodal spectroscopy (fluo-
rescence spectroscopy, elastic scattering spectroscopy and
Raman spectroscopy) has been shown to be capable of diag-
nosing malignant/precancerous tissue with a sensitivity and
specificity of 96%.14 The application of optical coherence
tomography (OCT) for the evaluation of oral cavity disease
began as early as 1998 when researchers obtained images of the
human tooth and oral mucosa.15 However, the range of speci-
ficity and sensitivity of optical biopsy varies widely due to the
inhomogeneity of oral cancers and premalignant lesions.
As a noninvasive and traditional technique, oral cavity
examination can be done quickly, is without additional diag-
nostic expense to patients and may be performed by health-care
professionals. The evidence regarding oral examination as anhinese Medical Association. All rights reserved.
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In a recently published randomized controlled trial with nearly
130,000 participants, investigators concluded that there was
insufficient evidence to support or refute the use of oral
examination as a screening program. However, this study, done
by the Kerala group in India, demonstrated improved survival
rates at 9 years among men with tobacco use as a high-risk
habit.7 Although there was no increase in survival for the
overall population, this study was the first to clearly support the
efficacy of an oral cancer screening program in a high-risk
population. In this issue,8 Chang et al report their evaluation
of 13,878 participants, in which the sensitivity and specificity
of oral cancer screening were 98.9% and 98.7%, respectively.
The relatively high levels of sensitivity and specificity make
visual screening superior to other oral examination protocols.
Meanwhile, aged males (40-years) or a high-risk population
(alcohol consumption, BQ chewing and cigarette use) were
recommended to receive oral screening periodically. This
conclusion is compatible with that of the Indian Kerala group.
Even with remarkable technological advancements made
by cancer advocates, researchers, and clinicians, the diagnosis
of oral cancer often occurs at a late stage, conferring a dismal
prognosis. Importantly, the improvement of patient outcomes
is related to the detection and surveillance of cancerous or
precancerous lesions at early stages of disease. Although many
of these techniques have been implemented in medical settings
only recently, they offer scientists highly sought-after methods
for the early detection of cancer. Many of the optical diag-
nostic techniques are still in the research and development
stages. In the contemporary era, visual screening still has the
highest effectiveness/price (e/p) value.
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